Griebeler Marcio L, Pantalone Kevin M, Gambino Ron, Shewmon David, Morrow Jay, Mendlovic Daniel, Makin Vinni, Hamaty Marwan, Hasan Sana, Lansang M Cecilia, Zhou Keren, Burguera Bartolome
Cleveland Clinic Lerner College of Medicine of Medicine of Case Western Reserve University, Cleveland, USA.
Endocrinology and Metabolism Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Clin Diabetes Endocrinol. 2021 Feb 9;7(1):5. doi: 10.1186/s40842-021-00118-7.
The COVID-19 pandemic has rapidly changed the landscape of medical care and the healthcare system needs to quickly adapt in order to continue providing optimal medical care to hospitalized patients in an efficient, effective, and safe manner. Endocrinology diseases are commonly present in patients with COVID-19 and often are major risk factors for development of severe disease. The use of electronic consultation and telemedicine have already been well-established in the outpatient setting but yet not commonly implemented in the inpatient arena. This type of remote medical care has the potential to provide a reliable delivery of endocrine care while protecting providers and patients from spreading infection. This short review intends to provide the initial steps for the development of an inpatient telemedicine endocrine service to patients with endocrine diseases. Telehealth will become part of our daily practices and has a potential to provide a safe and efficient method of consultative service.
新冠疫情迅速改变了医疗格局，医疗保健系统需要迅速适应，以便继续以高效、有效和安全的方式为住院患者提供最佳医疗服务。内分泌疾病在新冠患者中普遍存在，且往往是重症发生的主要危险因素。电子会诊和远程医疗在门诊环境中已得到广泛应用，但在住院领域尚未普遍实施。这种远程医疗有潜力在保护医护人员和患者免受感染传播的同时，提供可靠的内分泌护理服务。本简短综述旨在为开发针对内分泌疾病患者的住院远程医疗内分泌服务提供初步步骤。远程医疗将成为我们日常医疗实践的一部分，并有潜力提供一种安全高效的咨询服务方式。
